Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.
Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.
- Training, revamp of University system, Promote Translation of Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth
- Synthetic Biotechnology has tremendous potential, affordable gene sequencing can play a major role in the Food, Energy, fragrance & Flavors
Bharat Biotech and University of Maryland Accelerate Development of New Life Saving Conjugate Vaccine...
Receive USD 4 Million Award from The Wellcome Trust for Development and Clinical Trials Hyderabad, India, June 18, 2012: Bharat Biotech and The University of Maryland Center for Vaccine Development (“CVD”) announced today a significant milestone achievement– receiving a USD 4 Million Strategic Translation Award from The Wellcome Trust for clinical development of a new conjugate vaccine including initial clinical trials beginning in three years to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella (NTS). NTS have emerged as an important cause of invasive bloodstream infection in sub-Saharan Africa, among young children with malaria and malnutrition, and among adults with HIV. Strains of nontyphoidal Salmonella (“NTS”) that can cause systemic disease such as meningitis or sepsis are particularly common in sub-Saharan Africa; approximately 20 to 30% of children with such invasive NTS infections die.